Immune System Agents May Move Into Earlier Settings in GU Cancers
June 13th 2019Over the past 5 years, medical oncologists have witnessed the revolutionary impact of immunotherapy on patients with advanced urologic malignancies. Over the next 5 years, these therapies likely will similarly transform urologic surgical care.
Read More